We provide you with 20 years of free, institutional-grade data for DVAX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DVAX. Explore the full financial landscape of DVAX stock.
Total insider purchase within 3 month on this page: $41,116
Total insider selling within 3 month on this page: -$22,778,461
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Myers Scott Dunseth | Open Market Purchase | 3,800 | $10.82 | 2025-08-25 | |
| Deep Track Biotechnology Master Fund, Ltd. | Sale | -2,065,137 | $11.03 | $22,778,461 | 2025-08-22 |
| Emini Emilio | Grant, award...etc | 1,439 | 2025-06-13 | ||
| MacGregor Brent | Grant, award...etc | 5,758 | 2025-06-13 | ||
| CANO FRANCIS | Grant, award...etc | 5,758 | 2025-06-13 | ||
| Sun Elaine D | Grant, award...etc | 5,758 | 2025-06-13 | ||
| Paradiso Peter R. | Grant, award...etc | 5,758 | 2025-06-13 | ||
| SILVERNAIL LAUREN P | Grant, award...etc | 1,439 | 2025-06-13 | ||
| Myers Scott Dunseth | Grant, award...etc | 5,758 | 2025-06-13 | ||
| KISNER DANIEL L | Grant, award...etc | 5,758 | 2025-06-13 | ||
| Novack David F | Sale | -10,000 | $14 | $140,000 | 2025-03-26 |
| Novack David F | Derivatives Exercise | 10,000 | 2025-03-26 | ||
| Novack David F | Sale | -14,020 | $13.58 | $190,392 | 2025-03-20 |
| Novack David F | Sale | -32,764 | $14.39 | $471,474 | 2025-03-10 |
| Slebir John L | Sale | -5,358 | $12.93 | $69,279 | 2025-02-21 |
| Slebir John L | Derivatives Exercise | 16,667 | 2025-02-21 | ||
| Slebir John L | RSU | 16,667 | 2025-02-21 | ||
| Novack David F | Sale | -10,665 | $12.93 | $137,898 | 2025-02-20 |
| Novack David F | Derivatives Exercise | 22,620 | 2025-02-20 | ||
| Novack David F | RSU | 22,620 | 2025-02-20 | ||
| MacDonald Kelly | Sale | -4,975 | $12.93 | $64,327 | 2025-02-20 |
| MacDonald Kelly | Derivatives Exercise | 15,477 | 2025-02-20 | ||
| MacDonald Kelly | RSU | 15,477 | 2025-02-20 | ||
| Spencer Ryan | Sale | -36,528 | $12.93 | $472,307 | 2025-02-20 |
| Spencer Ryan | Derivatives Exercise | 55,000 | 2025-02-20 | ||
| Spencer Ryan | RSU | 55,000 | 2025-02-20 | ||
| Janssen Robert | Sale | -4,041 | $12.93 | $52,250 | 2025-02-20 |
| Janssen Robert | Derivatives Exercise | 11,904 | 2025-02-20 | ||
| Janssen Robert | RSU | 11,904 | 2025-02-20 | ||
| Janssen Robert | Sale | -4,614 | $12.69 | $58,552 | 2025-02-18 |
| Janssen Robert | Derivatives Exercise | 13,000 | 2025-02-18 | ||
| Janssen Robert | RSU | 13,000 | 2025-02-18 | ||
| MacDonald Kelly | Sale | -5,318 | $12.69 | $67,485 | 2025-02-18 |
| MacDonald Kelly | Derivatives Exercise | 16,000 | 2025-02-18 | ||
| MacDonald Kelly | RSU | 16,000 | 2025-02-18 | ||
| Novack David F | Sale | -12,480 | $12.69 | $158,371 | 2025-02-18 |
| Novack David F | Derivatives Exercise | 26,500 | 2025-02-18 | ||
| Novack David F | RSU | 26,500 | 2025-02-18 | ||
| Spencer Ryan | Sale | -31,694 | $12.69 | $402,197 | 2025-02-18 |
| Spencer Ryan | Derivatives Exercise | 62,500 | 2025-02-18 | ||
| Spencer Ryan | RSU | 62,500 | 2025-02-18 | ||
| Slebir John L | Sale | -4,708 | $12.69 | $59,745 | 2025-02-18 |
| Slebir John L | Derivatives Exercise | 14,000 | 2025-02-18 | ||
| Slebir John L | RSU | 14,000 | 2025-02-18 | ||
| Spencer Ryan | Sale | -11,209 | $13.2 | $147,959 | 2025-02-12 |
| Spencer Ryan | Derivatives Exercise | 20,833 | 2025-02-12 | ||
| Spencer Ryan | RSU | 20,833 | 2025-02-12 | ||
| MacDonald Kelly | Sale | -1,997 | $13.2 | $26,360 | 2025-02-12 |
| MacDonald Kelly | Derivatives Exercise | 5,333 | 2025-02-12 | ||
| MacDonald Kelly | RSU | 5,333 | 2025-02-12 | ||
| Janssen Robert | Sale | -1,781 | $13.2 | $23,509 | 2025-02-12 |
| Janssen Robert | Derivatives Exercise | 4,333 | 2025-02-12 | ||
| Janssen Robert | RSU | 4,333 | 2025-02-12 | ||
| Burgess Justin | Sale | -2,496 | $13.2 | $32,947 | 2025-02-12 |
| Burgess Justin | Derivatives Exercise | 6,666 | 2025-02-12 | ||
| Burgess Justin | RSU | 6,666 | 2025-02-12 | ||
| Novack David F | Sale | -4,518 | $13.2 | $59,638 | 2025-02-12 |
| Novack David F | Derivatives Exercise | 8,833 | 2025-02-12 | ||
| Novack David F | RSU | 8,833 | 2025-02-12 | ||
| Slebir John L | Sale | -1,747 | $13.2 | $23,060 | 2025-02-12 |
| Slebir John L | Derivatives Exercise | 4,666 | 2025-02-12 | ||
| Slebir John L | RSU | 4,666 | 2025-02-12 | ||
| Deep Track Biotechnology Master Fund, Ltd. | Initial | 2024-10-24 | |||
| CANO FRANCIS | Sale | -3,615 | $11.93 | $43,127 | 2024-06-03 |
| MacGregor Brent | Grant, award...etc | 5,357 | 2024-05-28 | ||
| Paradiso Peter R. | Grant, award...etc | 5,357 | 2024-05-28 | ||
| Phillips Peggy V | Grant, award...etc | 5,357 | 2024-05-28 | ||
| CANO FRANCIS | Sale | -3,885 | $11.39 | $44,250 | 2024-05-28 |
| CANO FRANCIS | Derivatives Exercise | 7,500 | 2024-05-28 | ||
| CANO FRANCIS | Grant, award...etc | 5,357 | 2024-05-28 | ||
| Sun Elaine D | Grant, award...etc | 5,357 | 2024-05-28 | ||
| KISNER DANIEL L | Grant, award...etc | 5,357 | 2024-05-28 | ||
| Myers Scott Dunseth | Grant, award...etc | 5,357 | 2024-05-28 | ||
| EASTLAND JULIA MARIE | Grant, award...etc | 5,357 | 2024-05-28 | ||
| Slebir John L | Initial | 2024-04-05 | |||
| Burgess Justin | Sale | -20,526 | $12.78 | $262,322 | 2024-03-04 |
| Burgess Justin | Derivatives Exercise | 7,101 | 2024-03-04 | ||
| Burgess Justin | Sale | -2,378 | $12.41 | $29,511 | 2024-02-20 |
| Burgess Justin | Derivatives Exercise | 6,667 | 2024-02-20 | ||
| Burgess Justin | RSU | 6,667 | 2024-02-20 | ||
| Novack David F | Grant, award...etc | 1,207 | $9.45 | 2024-02-20 | |
| Spencer Ryan | Grant, award...etc | 402 | $9.45 | 2024-02-20 | |
| Novack David F | Sale | -3,151 | $12.82 | $40,396 | 2024-02-13 |
| Novack David F | Derivatives Exercise | 8,833 | 2024-02-13 | ||
| Novack David F | RSU | 8,833 | 2024-02-13 | ||
| Janssen Robert | Sale | -1,531 | $12.82 | $19,627 | 2024-02-13 |
| Janssen Robert | Derivatives Exercise | 4,333 | 2024-02-13 | ||
| Janssen Robert | RSU | 4,333 | 2024-02-13 | ||
| Spencer Ryan | Sale | -11,684 | $12.82 | $149,789 | 2024-02-13 |
| Spencer Ryan | Derivatives Exercise | 20,833 | 2024-02-13 | ||
| Spencer Ryan | RSU | 20,833 | 2024-02-13 | ||
| Burgess Justin | Sale | -2,499 | $12.82 | $32,037 | 2024-02-13 |
| Burgess Justin | Derivatives Exercise | 6,667 | 2024-02-13 | ||
| Burgess Justin | RSU | 6,667 | 2024-02-13 | ||
| MacDonald Kelly | Sale | -2,985 | $12.82 | $38,268 | 2024-02-13 |
| MacDonald Kelly | Derivatives Exercise | 5,333 | 2024-02-13 | ||
| MacDonald Kelly | RSU | 5,333 | 2024-02-13 | ||
| Janssen Robert | Sale | -4,043 | $12.79 | $51,710 | 2024-02-07 |
| Janssen Robert | Derivatives Exercise | 10,000 | 2024-02-07 | ||
| Janssen Robert | RSU | 10,000 | 2024-02-07 | ||
| Burgess Justin | Sale | -3,448 | $12.79 | $44,100 | 2024-02-06 |
| Burgess Justin | Derivatives Exercise | 8,416 | 2024-02-06 | ||
| Burgess Justin | RSU | 8,416 | 2024-02-06 | ||
| Janssen Robert | Sale | -4,043 | $10.36 | $41,885 | 2024-02-06 |
| Janssen Robert | Derivatives Exercise | 10,000 | 2024-02-06 | ||
| Janssen Robert | RSU | 10,000 | 2024-02-06 | ||
| Spencer Ryan | Sale | -17,129 | $12.79 | $219,080 | 2024-02-06 |
| Spencer Ryan | Derivatives Exercise | 29,750 | 2024-02-06 | ||
| Spencer Ryan | RSU | 29,750 | 2024-02-06 | ||
| Novack David F | Sale | -6,688 | $12.79 | $85,540 | 2024-02-06 |
| Novack David F | Derivatives Exercise | 17,500 | 2024-02-06 | ||
| Novack David F | RSU | 17,500 | 2024-02-06 | ||
| Janssen Robert | Sale | -1,500 | $15 | $22,500 | 2024-01-08 |
| Janssen Robert | Derivatives Exercise | 1,500 | 2024-01-08 | ||
| Novack David F | Sale | -9,000 | $14.45 | $130,050 | 2024-01-04 |
| Novack David F | Derivatives Exercise | 9,000 | 2024-01-04 | ||
| Novack David F | Sale | -20,000 | $13.56 | $271,200 | 2023-12-05 |
| Novack David F | Derivatives Exercise | 20,000 | 2023-12-05 | ||
| Novack David F | Sale | -20,000 | $15 | $300,000 | 2023-11-07 |
| Novack David F | Derivatives Exercise | 20,000 | 2023-11-07 | ||
| Novack David F | Sale | -20,000 | $14.12 | $282,400 | 2023-11-03 |
| Novack David F | Derivatives Exercise | 20,000 | 2023-11-03 | ||
| Janssen Robert | Sale | -1,755 | $15.01 | $26,343 | 2023-10-11 |
| Janssen Robert | Derivatives Exercise | 1,755 | 2023-10-11 | ||
| Novack David F | Sale | -40,000 | $14.75 | $590,000 | 2023-10-04 |
| Novack David F | Derivatives Exercise | 40,000 | 2023-10-04 | ||
| Janssen Robert | Sale | -5,015 | $15.03 | $75,375 | 2023-10-03 |
| Janssen Robert | Derivatives Exercise | 5,015 | 2023-10-03 | ||
| Novack David F | Sale | -20,000 | $14.48 | $289,600 | 2023-09-05 |
| Novack David F | Derivatives Exercise | 20,000 | 2023-09-05 | ||
| Janssen Robert | Sale | -600 | $15.02 | $9,012 | 2023-08-25 |
| Janssen Robert | Derivatives Exercise | 600 | 2023-08-25 | ||
| Janssen Robert | Sale | -34,857 | $15.01 | $523,204 | 2023-08-24 |
| Janssen Robert | Derivatives Exercise | 34,857 | 2023-08-24 | ||
| Hack Andrew A. F. | Sale | -1,500,000 | $14.39 | $21,585,000 | 2023-08-10 |
| Novack David F | Sale | -40,000 | $14.74 | $589,600 | 2023-08-10 |
| Novack David F | Derivatives Exercise | 40,000 | 2023-08-10 | ||
| Janssen Robert | Sale | -2,600 | $15.05 | $39,130 | 2023-08-09 |
| Janssen Robert | Derivatives Exercise | 2,600 | 2023-08-09 | ||
| Burgess Justin | Sale | -8,061 | $14.54 | $117,247 | 2023-08-08 |
| Burgess Justin | Derivatives Exercise | 8,061 | 2023-08-08 | ||
| Hack Andrew A. F. | Sale | -500,000 | $12.68 | $6,340,000 | 2023-06-16 |
| Myers Scott Dunseth | Grant, award...etc | 5,357 | 2023-05-31 | ||
| Sun Elaine D | Grant, award...etc | 5,357 | 2023-05-31 | ||
| Phillips Peggy V | Grant, award...etc | 5,357 | 2023-05-31 | ||
| Hack Andrew A. F. | Grant, award...etc | 5,357 | 2023-05-31 |
The information provided in this report about DVAX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Dynavax Technologies Corporation(NASDAQ:DVAX)Â 
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older ...
Website: http://www.dynavax.com
Founded: 1996
Full Time Employees: 231
Sector: Healthcare
Industry: Biotechnology